Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P50
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2024-11.37%
202324.28%
202250.63%
2021-32.88%
2020-295.08%
201959.87%
2018-437.43%
2017172.06%
2016-57.02%
201534.66%